Read + Share
Amedeo Smart
Independent Medical Education
Kim TH, Choi JH, Ahn MS, Lee HW, et al. Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study. BMC Cancer 2024;24:70.PMID: 38216948
Email
LinkedIn
Facebook
Twitter
Privacy Policy